Aplantex Secures $3.3M Round of Funding

Patrick Charest, B. SC., P.Eng., CEO of Aplantex, said, 'It is with determination that the entire Aplantex team follows its game plan with discipline to become a leading supplier of high-value molecules to the pharmaceutical, cosmetics, and agri-food industries in the context of the international growth of the circular economy. We are encouraged to continue our tireless efforts by the significant support from leading private investors as well as government and institutional sources that contributed to the success of our second round of financing.'
Patrick Charest, B. SC., P.Eng., CEO of Aplantex, said, "It is with determination that the entire Aplantex team follows its game plan with discipline to become a leading supplier of high-value molecules to the pharmaceutical, cosmetics, and agri-food industries in the context of the international growth of the circular economy. We are encouraged to continue our tireless efforts by the significant support from leading private investors as well as government and institutional sources that contributed to the success of our second round of financing."

Aplantex has secured $3.3 million in funding, which will be used to increase the production volume of the Boucherville research and production center to meet this anticipated demand.

Patrick Charest, B. SC., P.Eng., CEO of Aplantex, said, "It is with determination that the entire Aplantex team follows its game plan with discipline to become a leading supplier of high-value molecules to the pharmaceutical, cosmetics, and agri-food industries in the context of the international growth of the circular economy. We are encouraged to continue our tireless efforts by the significant support from leading private investors as well as government and institutional sources that contributed to the success of our second round of financing."

More in News